Lallemand Bio-Ingredients acquires enzyme specialist Solyve

Zug, Switzerland, July 3, 2025- At Lallemand Bio-Ingredients, we are committed to advancing microbial solutions for the food and beverage industry. We are therefore pleased to announce the acquisition of Solyve, a subsidiary of the InVivo group.

Solyve is a leading producer of classical enzymes through solid-state fermentation at its modern facility in Normandy, France. Founded in 1989 as Lyven S.A., the company has developed a range of high-performance enzymes primarily for winemaking, juice & vegetable processing, and plant-based foods.

“Solyve brings a complementary set of capabilities and products to Lallemand Bio-Ingredients’ rapidly expanding enzyme business,” said Lars Asferg, President & General Manager of Lallemand Bio-Ingredients. “Solyve’s expertise in enzyme solutions will enhance our ability to support customers seeking high-performance enzymes across a wide range of food and beverage applications, and will strengthen our drive to bring enzyme innovation to market based on Lallemand’s unique technology platform.”

About Lallemand

Lallemand is a privately held global company, headquartered in Canada, whose focus is on the development, production and marketing of yeasts, bacteria, fungi and enzyme based solutions across the baking, food ingredients, human and animal nutrition and health, biofuels & distilled spirits, crop protection/nutrition, oenology and brewing sectors. Lallemand is present in more than 50 countries, operates more than 50 production plants and has circa 5,500 employees.

For more information, please visit the website: www.lallemand.com

Lallemand – Lars Asferg, President Lallemand Bio-Ingredients lasferg@lallemand.com + 41 79 566 6059